QTREX Quantum Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $106.6M
- Price
- $1.59
- % Change (Daily % change from the live per-ticker quote feed.)
- +3.25%
- Volume
- 71.4M
About
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
Quick stats
Shares outstanding67.1M
Computed float62.8M
Float / shares93.6%
Cash runway (months)27.3
Key info
SectorTechnology
IndustryComputer Hardware
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001837493
Websitehttps://www.q-trex.com
AI Summary
AI-generated1/27
standardbullishoperations update
QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader
QTREX Quantum announced independent testing of its AME cryogenic interconnect at 20 millikelvin by a leading quantum computing company, confirming better than 100 dB channel isolation across the 4-8 GHz qubit band.
The result exceeds the published 40 dB crosstalk specification of the leading flexible cryogenic cabling by more than 60 dB, with insertion loss of about 1 dB at 1 GHz and 2 dB at 6 GHz including connectors.
On the strength of the results, QTREX and the unnamed testing company are finalizing a binding definitive agreement, with the counterparty's name and terms to be disclosed within weeks. The company also expects additional quantum computing agreements in Q4 2026.
Red flags
- testing counterparty remains unnamed; definitive agreement not yet signed
- agreement terms undisclosed — commercial value not yet quantified
- pre-commercial-stage company; no revenue figures provided